Gujarat Kidney & Super Speciality IPO GMP History
Gujarat Kidney & Super Speciality IPO has been listed on December 30, 2025 at a listing price of ₹120, against the issue price of ₹114 — a gain of ₹6 (+5.26%). The GMP peaked at ₹55 on 4 January 2026 and reached a low of ₹55 on 4 January 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Gujarat Kidney & Super Speciality IPO raised ₹250.80 Cr. through its IPO at a price band of ₹108 to 114 per share, with a lot size of 128 shares. The IPO was open for subscription from 22 Dec 2025 to 24 Dec 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 27 Aug, 12:00 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 04 Jan 2026 | ₹ 55 | — | 10%% | — | — |
Gujarat Kidney & Super Speciality IPO dates
Key dates from opening to listing. Today is 30 October.
- Open 22 Dec 2025
- Close 24 Dec 2025
- Allotment 26 Dec 2025
- Refund/credit 29 Dec 2025
- Listing 30 Dec 2025
Gujarat Kidney & Super Speciality IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹114 |
|---|---|
| GMP-based estimate (pre-listing) | ₹163 (+50.9%) |
| Listing gain / loss | +₹6 per share |
| Listing date | 30 Dec, 2025 |
| Actual listing price | ₹120 (+5.26%) |
Is Gujarat Kidney & Super Speciality IPO GMP reliable?
Grey market premium for Gujarat Kidney & Super Speciality IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Gujarat Kidney & Super Speciality IPO full review for a fundamentals-based assessment before making any grey market trades.
Gujarat Kidney & Super Speciality IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Gujarat Kidney & Super Speciality IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Gujarat Kidney & Super Speciality IPO
Gujarat Kidney & Super Speciality Hospital was established with the aim of providing advanced and affordable healthcare services, particularly in nephrology and critical care. Over the years, the hospital has built a strong reputation in Gujarat for its specialised treatment of kidney-related diseases, dialysis services, and multi-speciality care. The institution is promoted by experienced medical professionals and healthcare entrepreneurs who bring deep domain expertise and a patient-centric approach. With a focus on quality treatment and modern medical infrastructure, the hospital has expanded its capabilities to cater to a growing patient base across the region.
The hospital offers a wide range of services including nephrology, urology, cardiology, intensive care, and other super speciality treatments. It is equipped with advanced dialysis units, operation theatres, and diagnostic facilities to support comprehensive patient care. The business model is primarily service-driven, generating revenue through consultations, procedures, diagnostic services, and inpatient care. By maintaining a balance between affordability and quality, the hospital aims to serve both urban and semi-urban populations while building long-term trust and relationships with patients.
Frequently asked
What is the GMP of Gujarat Kidney & Super Speciality IPO?
The current Grey Market Premium (GMP) of Gujarat Kidney & Super Speciality IPO is ₹ 55.
What is the Kostak Price of Gujarat Kidney & Super Speciality IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Gujarat Kidney & Super Speciality IPO is not available.
What is the Subject to Sauda Price of Gujarat Kidney & Super Speciality IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Gujarat Kidney & Super Speciality IPO?
Gujarat Kidney & Super Speciality IPO listed on December 30, 2025 at ₹120, against the issue price of ₹114 — a gain of +5.26%.
How did the GMP of Gujarat Kidney & Super Speciality IPO trend before listing?
The GMP of Gujarat Kidney & Super Speciality IPO was stable in its final days before listing. The GMP peaked at ₹55 on 4 January 2026. View the day-wise table above for the complete GMP history.
Explore Gujarat Kidney & Super Speciality IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
